Alpine Global Management, LLC Kymera Therapeutics, Inc. Transaction History

Alpine Global Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $527,149 - $692,444	-10,562 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$47.8 - $66.66 $211,180 - $294,503	4,418 Added 71.91%	10,562 $656,000
Q2 2021 Aug 13, 2021	BUY	$31.08 - $51.95 $190,955 - $319,180	6,144 New	6,144 $298,000

184

64.4M

50.6K

81.7K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.